Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle

Published:2003-03-04 Issue:5 Volume:27 Page:624-627
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Dunant Patrick,Walter Maggie C.,Karpati George,Lochmüller Hanns

Funder

Muscular Dystrophy Association (MDA)

Muscular Dystrophy Association of Canada (MDAC)

Deutsche Forschungsgemeinschaft (DFG)

German Duchenne Parents Project (aktion benni und co.)

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Reference21 articles.

1. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy;Ahmad;Hum Mol Genet,2000

2. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice;Barton-Davis;J Clin Invest,1999

3. Genomic screening for β-sarcoglycan mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E);Bönnemann;Hum Mol Genet,1996

4. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis;Clancy;Am J Respir Crit Care Med,2001

5. DGGE analysis as a tool to identify point mutations, de novo mutations and carriers of the dystrophin gene;Dolinsky;Neuromuscul Disord,2002

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The BALB/c.mdx62 mouse exhibits a dystrophic muscle pathology and is a model of Duchenne muscular dystrophy;Disease Models & Mechanisms;2024-04-01

2. Readthrough Activators and Nonsense-Mediated mRNA Decay Inhibitor Molecules: Real Potential in Many Genetic Diseases Harboring Premature Termination Codons;Pharmaceuticals;2024-02-28

3. Amlexanox: Readthrough Induction and Nonsense-Mediated mRNA Decay Inhibition in a Charcot–Marie–Tooth Model of hiPSCs-Derived Neuronal Cells Harboring a Nonsense Mutation in GDAP1 Gene;Pharmaceuticals;2023-07-21

4. Nanomedicine for Treating Muscle Dystrophies: Opportunities, Challenges, and Future Perspectives;International Journal of Molecular Sciences;2022-10-10

5. Drug development progress in duchenne muscular dystrophy;Frontiers in Pharmacology;2022-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3